IDiyas

For the Inventor, By the Inventor

Fairfield, OH, United States of America

Russell James Sheldon

USPTO Granted Patents = 21

Average Co-Inventor Count = 3.4

ph-index = 11

Forward Citations = 289(Granted Patents)


Company Filing History:

goldMedal21 out of 17,164 
 
The Procter Gamble Company
 patents

Years Active: 1998-2009

Loading Chart...
21 patents (USPTO):Explore Patents
1. 7572768 - Methods for identifying compounds for regulating muscle mass or function using corticotropin releasing factor receptors (2009-08-11),
2. 7067113 - Methods for identifying compounds for regulating muscle mass or function using dopamine receptors (2006-06-27),
3. 7063954 - Methods for identifying compounds for regulating muscle mass or function using corticotropin releasing factor receptors (2006-06-20),
4. 6951916 - Melanocortin receptor ligands (2005-10-04),
5. 6750194 - Methods of identifying compounds for regulating muscle mass or function using vasoactive intestinal peptide receptors (2004-06-15),
6. 6670140 - Methods for identifying compounds for regulating muscle mass or function using corticotropin releasing factor receptors (2003-12-30),
7. 6613874 - Melanocortin receptor ligands (2003-09-02),
8. 6436978 - Guanidinylamino heterocycle compounds useful as &agr;-2 adrenoceptor agonists (2002-08-20),
9. 6423724 - 7-(2-imidazolinylamino) quinoline compounds useful as alpha-2 adrenoceptor agonists (2002-07-23),
10. 6395764 - 2-imidazolinylaminoindole compounds useful as alpha-2 adrenoceptor agnonists (2002-05-28),
11. 6391878 - Guanidinyl heterocycle compounds useful as alpha-2 adrenoceptor agonists (2002-05-21),
12. 6306877 - Guanidinylamino heterocycle compounds useful as alpha-2 adrenoceptor agonists (2001-10-23),
13. 6225331 - Guanidinyl heterocycle compounds useful as alpha-2 adrenoceptor agonists (2001-05-01),
14. 6172095 - Guanidinylamino heterocycle compounds useful as alpha-2 adrenoceptor agonists (2001-01-09),
15. 6162818 - 2-imidazolinylaminoindole compounds useful as alpha-2 adrenoceptor (2000-12-19),

Title: Innovator Spotlight: Russell James Sheldon

Introduction: Russell James Sheldon, a prolific inventor based in Fairfield, OH (US), has made significant contributions to the field of muscle function regulation through his groundbreaking research and patented innovations.

Latest Patents: Among his impressive portfolio of 21 patents, Russell James Sheldon's latest inventions focus on methods for identifying compounds that regulate muscle mass or function using corticotropin-releasing factor receptors and dopamine receptors. These patents showcase his dedication to advancing treatments for skeletal muscle-related conditions such as atrophy and muscular dystrophies.

Career Highlights: Currently employed at The Procter & Gamble Company, Russell James Sheldon continues to drive innovation in the healthcare and pharmaceutical industry. His expertise in biochemistry and pharmacology has led to the development of novel screening methods and pharmaceutical compositions aimed at enhancing skeletal muscle mass and function.

Collaborations: Russell James Sheldon has collaborated closely with notable coworkers such as Raymond Todd Henry and William Lee Seibel. Together, they have worked on cutting-edge research projects that have resulted in the successful identification of compounds targeting corticotropin-releasing factor receptors and dopamine receptors for therapeutic interventions.

Conclusion: In conclusion, Russell James Sheldon stands as a pioneering figure in the realm of muscle function regulation, with a track record of patented inventions that have the potential to revolutionize treatments for muscular conditions. His dedication to innovation and collaboration underscores his commitment to advancing the field of biochemistry and pharmaceutical sciences.

This text is generated by artificial intelligence and may not be accurate.
Please report any incorrect information to support@idiyas.com
Loading…